je.st
news
Gilead beats back Roche, wins U.K. victory for hepatitis C drug Sovaldi
2014-08-16 09:15:14| Biotech - Topix.net
An arbitration panel ruled Friday that the Foster City-based drug maker's hepatitis C blockbuster Sovaldi did not infringe a 2004 research deal that rival Roche had with Pharmasset Inc. Gilead , led by Chairman and CEO John Martin , bought Pharmasset in 2012 for $11 billion, landing the drug that would become Sovaldi.
Tags: back
drug
victory
wins
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||